These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3139778)

  • 1. Prevention of intra-abdominal abscesses by fibrinolysis using recombinant tissue plasminogen activator.
    Rotstein OD; Kao J
    J Infect Dis; 1988 Oct; 158(4):766-72. PubMed ID: 3139778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of intra-abdominal abscesses with fibrinolytic agents.
    Rosenthal GA; Quinto J; Kao J; Rotstein OD
    Can J Surg; 1988 Mar; 31(2):98-100. PubMed ID: 3127033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of recombinant tissue plasminogen activator on intra-abdominal abscess formation in rats with generalized peritonitis.
    van Goor H; de Graaf JS; Kooi K; Sluiter WJ; Bom VJ; van der Meer J; Bleichrodt RP
    J Am Coll Surg; 1994 Oct; 179(4):407-11. PubMed ID: 7921389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed administration of tissue plasminogen activator reduces intra-abdominal abscess formation.
    McRitchie DI; Cummings D; Rotstein OD
    Arch Surg; 1989 Dec; 124(12):1406-10. PubMed ID: 2511820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotics fail to prevent abscess formation secondary to bacteria trapped in fibrin clots.
    Hau T; Jacobs DE; Hawkins NL
    Arch Surg; 1986 Feb; 121(2):163-8. PubMed ID: 3511886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue plasminogen activator reverses the deleterious effect of infection on colonic wound healing.
    Houston KA; McRitchie DI; Rotstein OD
    Ann Surg; 1990 Feb; 211(2):130-5. PubMed ID: 2105700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.
    Rotstein OD; Kao J; Houston K
    J Med Microbiol; 1989 Aug; 29(4):269-76. PubMed ID: 2668529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gentamycin reduces bacteremia and mortality rates associated with the treatment of experimental peritonitis with recombinant tissue plasminogen activator.
    van Goor H; de Graaf JS; Kooi K; Bleichrodt RP
    J Am Coll Surg; 1995 Jul; 181(1):38-42. PubMed ID: 7599769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migration of rat peritoneal cells after intra-abdominal infection with Bacteroides fragilis and Escherichia coli.
    Verweij WR; Namavar F; Schouten WF; de Graaff J; MacLaren DM
    J Gen Microbiol; 1993 Aug; 139(8):1739-44. PubMed ID: 8409916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin in peritonitis. IV. Synergistic intraperitoneal infection caused by Escherichia coli and Bacteroides fragilis within fibrin clots.
    Dunn DL; Rotstein OD; Simmons RL
    Arch Surg; 1984 Feb; 119(2):139-44. PubMed ID: 6365029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of survival from murine polymicrobial peritonitis with increased abdominal abscess formation.
    Cheadle WG; Hershman MJ; Mays B; Melton L; Polk HC
    J Surg Res; 1989 Aug; 47(2):120-3. PubMed ID: 2502684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A standardised and reproducible model of intraabdominal infection and abscess formation in rats.
    Bosscha K; Nieuwenhuijs VB; Gooszen AW; van Duijvenbode-Beumer H; Visser MR; Verweij WR; Akkermans LM
    Eur J Surg; 2000 Dec; 166(12):963-7. PubMed ID: 11152259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of anaerobic bacteria in intra-abdominal septic abscesses in mediating septic control of skeletal muscle glucose oxidation and lactic acidemia.
    Vary TC; Siegel JH; Tall B; Morris JG
    J Trauma; 1989 Jul; 29(7):1003-13; discussion 1013-4. PubMed ID: 2664200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early events after intra-abdominal infection with Bacteroides fragilis and Escherichia coli.
    Verweij WR; Namavar F; Schouten WF; MacLaren DM
    J Med Microbiol; 1991 Jul; 35(1):18-22. PubMed ID: 2072375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
    van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
    Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-type plasminogen activator prevents formation of intra-abdominal abscesses after surgical treatment of secondary peritonitis in a rat model.
    Buyne OR; Bleichrodt RP; van Goor H; Verweij PE; Hendriks T
    Int J Colorectal Dis; 2007 Jul; 22(7):819-25. PubMed ID: 17089129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy and pharmacokinetic properties of ciprofloxacin in intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
    Fu KP; Vince T; Bloom R; Gregory FJ; Hung PP
    Drugs Exp Clin Res; 1987; 13(8):493-6. PubMed ID: 3322752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of glucan and cefoxitin in prevention of murine abscess.
    Hull CC; Stellato TA; Rhodes RS; Galloway P; Hawkins NL
    Curr Surg; 1986; 43(5):416-8. PubMed ID: 3533446
    [No Abstract]   [Full Text] [Related]  

  • 19. Aztreonam vs. gentamicin in experimental peritonitis and intra-abdominal abscess formation.
    Sawyer RG; Adams RB; Pruett TL
    Am Surg; 1994 Nov; 60(11):849-53. PubMed ID: 7978680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lethal microbial synergism in intra-abdominal infections. Escherichia coli and Bacteroides fragilis.
    Rotstein OD; Pruett TL; Simmons RL
    Arch Surg; 1985 Feb; 120(2):146-51. PubMed ID: 3156575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.